Lantheus Holdings, Inc. acquires Meilleur Technologies, Inc. to expand Alzheimer’s diagnostic capabilities
Acquiring Company
Lantheus Holdings
Acquired Company
Meilleur Technologies
BedfordDublinBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
Lantheus Holdings, Inc. announced its acquisition of Meilleur Technologies, Inc., which includes the next-generation ß amyloid PET imaging agent NAV-4694. This acquisition expands Lantheus’ Alzheimer’s disease pipeline and strengthens its diagnostic capabilities in line with updated guidelines developed by the National Institute on Aging and the Alzheimer's Association.
Quick answer
Lantheus Holdings is acquiring Meilleur Technologies, announced July 15, 2024. Lantheus Holdings is based in Bedford, Massachusetts, United States.
- How much did Lantheus Holdings pay for Meilleur Technologies?
- The deal value was not disclosed.
- What does Lantheus Holdings do?
- Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.
- Where are Lantheus Holdings and Meilleur Technologies based?
- Lantheus Holdings is based in Bedford, Massachusetts, United States. Meilleur Technologies is based in Dublin, Ohio, United States.
- Who are the decision-makers at Lantheus Holdings?
- Fundz holds 1 contact at Lantheus Holdings. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical (August 9, 2024)
- Merck completes acquisition of EyeBio to diversify its late-stage pipeline (July 12, 2024)
- Novartis BidCo Germany AG to Merge Squeeze-out MorphoSys AG’s Minority Shareholders (June 20, 2024)
- Novartis to merge with MorphoSys AG after successful acquisition and delisting agreement (June 20, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- Eli Lilly and Company completes $3.2 Billion Acquisition of Morphic Holding, Boosting Its IBD Pipeline, $3.2B (August 27, 2024)
Who to call at Lantheus Holdings, and when
When Lantheus Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lantheus Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lantheus Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lantheus Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lantheus Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Meilleur Technologies?
Meilleur Technologies was acquired by Lantheus Holdings, based in Bedford. The deal was reported on July 15, 2024. Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus Holdings is publicly traded (LNTH) and operates in Biotechnology.
When did Lantheus Holdings acquire Meilleur Technologies?
Lantheus Holdings's acquisition of Meilleur Technologies was reported on July 15, 2024. Lantheus Holdings, Inc. announced its acquisition of Meilleur Technologies, Inc., which includes the next-generation ß amyloid PET imaging agent NAV-4694. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Meilleur Technologies do?
It is privately held, operating in Biotechnology, and is based in Dublin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.